Premsingh N, Kapila R, Tecson F, Smith L G, Louria D B
Arch Intern Med. 1976 Feb;136(2):208-12.
On the basis of the data currently available, no dogmatic statements can be made about optimal therapy for Candida endocarditis. In those with valve protheses, early surgery should be carefully assessed even though the differences in outcome (17% vs 53% survival) are not yet statistically significant.
根据目前可得的数据,无法对念珠菌性心内膜炎的最佳治疗方法作出教条式的论断。对于有心脏瓣膜假体的患者,即使预后差异(生存率分别为17%和53%)尚无统计学意义,也应对早期手术进行仔细评估。